#fda--ftc-enforcement

#fda--ftc-enforcement

The EESC warns against 'excessive increases' on the grounds that they could fuel illicit trade, thereby recycling one of the tobacco industry's oldest false narratives arguments against stronger regulation.

The Office of Impact Analysis found that the government's preferred option would lower annual gambling expenditure by AUD 62.7 million, or 0.8 percent of the AUD 32.2 billion Australians lost on legal gambling in 2023-24.

"Given StubHub's experience and public support for the rule, I was disappointed to learn that it was allegedly one of the rule's first major violators," FTC Chair Andrew Ferguson said. "[...] StubHub chose to slow-walk compliance with the rule in part because the NFL was about to release its regular-season schedule."

Rebecca Fadanelli admitted guilt on four counts of importing merchandise contrary to law, two counts of selling or dispensing a counterfeit drug, and two counts of selling or dispensing a counterfeit device.

Lead plaintiff Anthony D'Antonio established he suffered a concrete injury sufficient to establish standing to sue in federal court, according to Judge Victor Marrero.

The proposed class-action lawsuit states that the plaintiffs received medical care at various Sutter and MemorialCare facilities, where medical staff used Abridge AI to record conversations.

When you purchase the top-selling creatine gummies on Amazon, you expect to get what you pay for. But a recent study found that four out of six popular brands contained virtually no creatine at all. In the case of the worst offender, customers would need to consume 2,000 gummies to get the advertised 5-gram dose. Still, combined these products sell over 50,000 units monthly and boast 4.4+ star ratings.

Laura CressTechnology reporter Fiordaliso via Getty Images Children are routinely exposed to adverts for weight loss injections and pills online, according to a report by the children's commissioner for England. It found young people were "routinely bombarded" with ads for products which claimed to change their bodies and appearance, despite this kind of advertising being banned. Dame Rachel de Souza said the posts were "immensely damaging" to young people's self-esteem and called for a ban on social media advertising to children.

The IRA requires drugmakers to sell selected patented drugs to the government for its Medicare Parts B & D programs at a stipulated "maximum fair price". If they don't agree to these prices, then they face tax penalties on sales of the drug exceeding their profits from it, or the exclusion of all their drugs from Medicare and Medicaid purchases. This would foreclose access to up to 160 million patients, accounting for around 40% of US prescription drug spending or 20% of global prescription drug spending.

The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the agency, stoking worries that the plan may run afoul of legal, ethical, and scientific standards long used to vet the safety and effectiveness of new medicines. Marty Makary's program is causing new anxiety and confusion among staff already rocked by layoffs, buyouts, and leadership upheavals, according to seven current or recently departed staffers.

Age verification technologies are some of the most child-protective technologies to emerge in decades. Our statement incentivizes operators to use these innovative tools, empowering parents to protect their children online.

These days, the internet "looks a hell of a lot more like Las Vegas than 'Little House on the Prairie.'" That's how Andrew Ferguson, chair of the Federal Trade Commission, described the online experience of children in his opening remarks for an FTC workshop on age verification last week. The event took place on Wednesday, January 28, which also happened to be Data Privacy Day, an annual "holiday" of sorts to raise awareness about privacy issues and encourage better data protection practices.

The U.S. Food and Drug Administration is reportedly mulling whether more prescription drugs should be sold over the counter (OTC) at pharmacies. In an interview on Wednesday, FDA commissioner Martin Makary told CNBC that everything should be over the counter except drugs that are deemed unsafe or addictive or that require clinical monitoring. Makary said the agency is reviewing how it decides which drugs can be sold with or without a prescription from a health care practitioner.

This week in Other Barks & Bites, IPWatchdog's IP news roundup: the House of Representatives passes drug patent legislation, while antitrust legislation targeting patent-related activities is introduced into the Senate and the Trump administration mandates pricing information for pharmaceutical ads; the Patent Trial and Appeal Board (PTAB) issues a pair of precedential decisions on cases with multiple petitions; the USPTO issues marijuana-related trademark guidelines and a notice on modifying patent term adjustment practices;

How do privacy regulators decide which companies to poke? Often, it's a consumer complaint. Other times, it's a headline. And, sometimes, it's just personal. Regulators are consumers, too, after all. But it's important to remember that every brush with a regulator doesn't turn into a full-blown case, said privacy attorney Tyler Bridegan. Bridegan spent nearly two years as director of privacy and tech enforcement for the Texas attorney general's office. He left government work and returned to private practice in October as a partner at Womble Bond Dickinson.